Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis.

MeiLan K HanGerard J CrinerMark T DransfieldDavid M G HalpinChristine E JonesSally KilbridePeter LangeSally LettisDavid A LipsonDavid A LomasNeil MartinFernando J MartinezRobert A WiseIan P NayaDave Singh

Published in: ERJ open research (2021)

Prevention of short-term disease worsening was associated with better long-term clinical outcomes. FF/UMEC/VI reduced CID risk versus dual therapies; this effect may improve long-term prognosis in this population.

Keyphrases

chronic obstructive pulmonary disease
clinical trial
study protocol
phase iii
open label